Novartis AG (NVS)
101.44
+1.23
(+1.23%)
USD |
NYSE |
May 10, 10:08
Novartis Total Long Term Debt (Quarterly): 25.53B for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 25.53B |
December 31, 2023 | 24.52B |
September 30, 2023 | 23.53B |
June 30, 2023 | 26.55B |
March 31, 2023 | 27.36B |
December 31, 2022 | 26.12B |
September 30, 2022 | 26.79B |
June 30, 2022 | 29.28B |
March 31, 2022 | 29.49B |
December 31, 2021 | 29.13B |
September 30, 2021 | 32.44B |
June 30, 2021 | 33.90B |
March 31, 2021 | 35.91B |
December 31, 2020 | 35.85B |
September 30, 2020 | 36.22B |
June 30, 2020 | 32.83B |
March 31, 2020 | 34.76B |
December 31, 2019 | 27.20B |
September 30, 2019 | 28.15B |
June 30, 2019 | 28.22B |
March 31, 2019 | 28.65B |
December 31, 2018 | 32.09B |
September 30, 2018 | 31.78B |
June 30, 2018 | 32.36B |
March 31, 2018 | 34.11B |
Date | Value |
---|---|
December 31, 2017 | 28.42B |
September 30, 2017 | 30.16B |
June 30, 2017 | 30.56B |
March 31, 2017 | 31.26B |
December 31, 2016 | 23.69B |
September 30, 2016 | 26.57B |
June 30, 2016 | 26.37B |
March 31, 2016 | 28.09B |
December 31, 2015 | 21.90B |
September 30, 2015 | 22.70B |
June 30, 2015 | 23.27B |
March 31, 2015 | 25.11B |
December 31, 2014 | 20.36B |
September 30, 2014 | 19.61B |
June 30, 2014 | 20.43B |
March 31, 2014 | 21.21B |
December 31, 2013 | 17.92B |
September 30, 2013 | 18.78B |
June 30, 2013 | 18.87B |
March 31, 2013 | 20.94B |
December 31, 2012 | 19.73B |
September 30, 2012 | 20.84B |
June 30, 2012 | 22.63B |
March 31, 2012 | 24.59B |
December 31, 2011 | 20.23B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
23.53B
Minimum
Sep 2023
36.22B
Maximum
Sep 2020
29.69B
Average
28.68B
Median
Total Long Term Debt (Quarterly) Benchmarks
Roche Holding AG | 34.77B |
Sandoz Group AG | -- |
Amgen Inc | 64.02B |
Incyte Corp | 0.00 |
MorphoSys AG | 689.22M |